DAPAGLIFLOZIN VERSUS A DIPEPTIDYL PEPTIDASE 4 INHIBITOR (DPP4) BOTH ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): IMPACT ON HEALTH, QUALITY OF LIFE AND COSTS IN THE TURKISH CLINICAL SETTING

View/Open

PIIS1098301515041728.pdf (51.46Kb)

Date

2015

Author

Malhan, S.

Guler, S.

Yetkin, I.

Ignacio, T.J.

Verheggen, B.

Charokopou, M.

Metadata

Show full item record

URI

https://www.valueinhealthjournal.com/article/S1098-3015(15)04172-8/pdf
http://hdl.handle.net/11727/4055

Collections

• Sağlık Hizmetleri Meslek Yüksekokulu / Vocational School of Health Services [59]